CIP
MDCO

Convergence Investment Partners’s Medicines Co MDCO Stock Holding History

Convergence Investment Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-82,696
Closed -$2.4M – 448
2014
Q2 		$2.4M Buy
+82,696
New +$2.21M 0.32% 113

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Convergence Investment Partners's MDCO Position: Q3 2014 in Review

Convergence Investment Partners sold out of Medicines Co (MDCO) in Q3 2014, closing a stake of 82,696 shares — an estimated $2.4M sold.

Convergence Investment Partners first reported a position in MDCO in Q2 2014 and held it in 1 quarter. The position peaked at $2.4M in Q2 2014. 152 funds tracked by Wall St. Rank hold MDCO as of Q3 2014.

  • Convergence Investment Partners reported no remaining Medicines Co position as of Q3 2014 after selling out during the quarter.
  • Convergence Investment Partners sold 82,696 Medicines Co shares in Q3 2014, an estimated $2.4M.
  • Convergence Investment Partners first reported a position in Medicines Co in Q2 2014 and held it in 1 quarter.
  • Convergence Investment Partners's Medicines Co position peaked at $2.4M in Q2 2014.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q3 2014.

Based on Convergence Investment Partners's 13F filing for Q3 2014, filed 12 Nov 2014.